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Abstract 
Spinal epidural lipomatosis (SEL) is a 
pathological condition in which fat tissue is 
deposed in the spinal canal around the 
thecal sac in excess, causing neurological 
symptomatology (7, 9, 12). Fat tissue is 
present in our body almost everywhere. 
When the normal quantity is exceeded is 
created a pathological situation.  
We present a 33 old man case with fat 
tissue excess deposited in lumbar spine 
canal. The pathological history of our 
patient includes a nodular form of stage IA 
Hodgkin lymphoma diagnosed in 2011 for 
what he went combined radio-
chemotherapy. He also has ben diagnosed 
with grad I obesity. In last month he 
presented with rapidly progressive 
symptoms like lower back pain, paraparesis 
and sphincters dysfunctions.  
Thoracic magnetic resonance imaging 
(MRI) establishes a lumbar lipomatosis 
located in L3-S5 spinal canal. Pathology 
results confirm the imagistic diagnostic. 
Under surgery was performed a median 
laminectomy with fat tissue excision with 
good results in patient symptomatology.  
Cortisone chronic therapy may lead to 
SEL. However in our case, Hodgkin 
lymphoma therapy appeared to be related to 
cortisone therapy. Neurological 
symptomatically patients should be treated 
surgically.  
Key words: Lumbar pain; Lipomatosis; 
Hodgkin disease; Radio-chemotherapy 
complications. 
Introduction 
Lumbar lipomatosis represents a 
pathological situation in which the fat tissue 
is deposed in excess in spinal canal (7, 8, 9). 
Fat tissue is present in our body almost 
everywhere. In spinal canal has a protective 
roll for spine and nerves (5, 9). When is in 
excess it creates neurological 
symptomatology. Lipomatosis is known to 
be a complication for chronic steroids 
therapy with neurological symptoms (8, 
12). There were several other cases reported 
in which chronic steroids therapy lead to 
spinal lipomatosis (1, 10, 11, 15). Another 
case of spinal lipomatosis was in a patient 
with Cushing syndrome (1). We know that 
corticoids may influence the adipose tissue 
deposits. We present a similar case of a 
patient that was diagnosed with lumbar 
lipomatosis after he underwent 
radiotherapy with high doses of prednisone.  
Case presentation 
 A 33 years old patient presented at our 
clinic with rapidly progressive symptoms 
like lower back pain, paraparesis and 
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sphincters dysfunctions during the last 
month. From his medical history we know 
that he suffer an appendicectomy in 2009 
that continued with abdominal pain and in 
2010 he was diagnosed with inguinal 
adenopathy. In 2011 he suffer a surgery 
intervention to remove the nodular 
formation. The patient was diagnosed with 
stage IA nodular form of Hodgkin 
lymphoma. The diagnosis was sustained by 
pathology result from the lesion. A PET-
CT was made to evaluate the lesion 
extension. The result was negative for any 
other lymphoma extension after first 
session of chemotherapy. He underwent 
combined radio-chemotherapy after 
surgery. He underwent 4 sessions of 
chemotherapy with R-CHOP (rituximab, 
cyclophosphamide, doxorubicin, 
vincristine, prednisone) (17). The 
neurological symptoms starts after several 
months but in the last month they 
exacerbate rapidly affecting the motor 
functions and his quality of life. On the 
general exam we noticed that his body mass 
index (BMI) was 31 indicating grad I 
obesity. Neurological exam revealed motor 
and sensory dysfunction on L3-S5 
dermatomes with external popliteal sciatic 
(EPS) paresis more evident on the left side 
and perineal paresis. He also had sphincter 
dysfunction with urinary problems. His 
clinical diagnosis was compressive 
myelopathy with cauda equine syndrome. 
The routinely laboratory and biochemical 
tests showed normally hematological 
parameters.  The magnetic resonance 
imaging (MRI) of lumbar spine (Figure 1, 
Figure 2, Figure 3) whoever revealed high-
intensity fat within in the lumbar spinal 
canal. After preoperative planning our team 
managed to operate.  
 
Figure 1 T1 MRI lumbar column sagittal incidence 
 
 
Figure 2 T2 MRI lumbar column sagittal incidence 
 
A medial laminectomy L5and S1was 
performed with adipose tissue excision and 
nerve route decompression at the same 
levels. A tissue sample was taken for 
pathology. The result was positive for 
mature adipose tissue without lymphocyte 
infiltration (Figure 4).  
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Figure 3 T2 MRI lumbar column axillar incidence 
 
 
Figure 4 histological examinations demonstrate 
nodular proliferation of mature fat cells 
 
Symptoms were improved after surgery 
but the patient also needs kinesiology for 
full recovery. The diagnosed was 
lumbosacral lipomatosis, grad I obesity, and 
stage IA nodular form of Hodgkin 
lymphoma. 
Discussion 
Spinal epidural lipomatosis (SEL) is a 
pathological condition in which fat tissue is 
deposed in the spinal canal around the 
thecal sac in excess, causing neurological 
symptomatology (7, 9, 12). Physiological 
the adipose tissue in spinal canal has a 
protective roll for spinal cord (5, 9). The 
adipose tissue thickness varies with spinal 
canal levels. In the cervical region the 
adipose tissue is almost inexistent. In 
thoracic region the distribution of epidural 
fat is patchy. In the lumbar region the 
epidural fat acquire it greatest volume (2, 
9). The SEL etiology is unknown (12) but 
there are some risks factors causing the 
adipose tissue to gather in excess. Some of 
this includes Cushing disease, obesity, 
epidural steroid injection, hypothyroidism, 
pituitary prolactinoma, renal transplants, 
rheumatoid arthritis, exogenous 
corticosteroid therapy, spinal anesthesia and 
idiopathic (1, 3, 4, 7, 10, 11, 12, 13, 14). Off 
all this most common is exogenous 
corticosteroid therapy (11, 12, 16).  
Spinal epidural lipomatosis could be 
found in patients with Cushing syndrome 
and morbid obesity (1, 13, 14). There were 
some other cases in the literature of spinal 
epidural lipomatosis due to corticoid 
therapy (8, 11, 16).  
The best way to evaluate the adipose 
tissue in the spinal canal is by magnetic 
resonance imaging (MRI) (2, 7, 8, 9, 10). 
Borré (2) manage to evaluate the normal 
thickness of adipose tissue in the lumbar 
spinal canal and classify it in 4 grades. 
Grade 0 represents the normal value of 
adipose tissue in lumbar region. 
Lumbosacral epidural lipomatosis (LEL) 
grade III is symptomatic, grade II only in 
14.5% symptomatic and no symptoms in 
grade I (2, 7). Although our patient had a 
grade II LEL (2), he had neurological 
symptoms that affect his quality of life. In 
our patient, signal intensity alterations were 
observed in lumbosacral level. The MRI 
reveals massive adipose tissue in 
lumbosacral with highest thickness of 
0.997mm (Fig. 3). He suffers corticoid 
therapy after Hodgkin lymphoma 
diagnostic. One of the steps of the stage IA 
Hodgkin lymphoma protocol includes 
chemotherapy with R-CHOP (17). He 
underwent 4 sessions of chemotherapy in 4 
moths period. PET-CT investigation did 
not confirm any dissemination after the 
first chemotherapy session. He underwent 
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radiotherapy with interferon (IF) 20Gy/ 
10fr 2Gy/ fr on iliac ganglions. His 
neurological symptoms appear 5 months 
after chemotherapy with rapidly developing 
in the last month.  
The patient was not on corticoid therapy 
on the time that symptomology increase 
and we did not find any connection 
between radiotherapy and spinal 
lipomatosis (3, 8, 11). 
There are various methods of therapy (1, 
11, 13, 14, 15, 16). However is a matter of 
debate, what treatment is best for the 
patient. There were good results only with 
conservative treatment. However the 
treatment should be determined according 
to each case (1, 3, 10, 13, 14, 15, 16). In our 
case the patient has rapidly neurological 
symptoms evolution that required surgical 
treatment with nerve routs decompression. 
The differential diagnostic included spinal 
tumor, dural lymphoma and angiolipoma, 
which needed also surgery treatment (4, 6). 
After the surgery recommendations 
included loose weight and neurological 
rehabilitation. 
Conclusion 
Cortisone chronic therapy may lead to 
SEL. However in our case, Hodgkin 
lymphoma therapy led to cortisone 
complications. We did not find any 
radiotherapy implication in the literature. 
However the patient suffer for grad I 
obesity. Neurological symptomatically 
patients should be treated surgically. 
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